Show simple item record

dc.contributor.authorMishra, Ajay
dc.contributor.authorGeorge, Anu Anna
dc.contributor.authorSahu, Kamal Kant
dc.contributor.authorLal, Amos
dc.contributor.authorAbraham, George M
dc.date2022-08-11T08:08:10.000
dc.date.accessioned2022-08-23T15:44:46Z
dc.date.available2022-08-23T15:44:46Z
dc.date.issued2020-11-10
dc.date.submitted2021-03-22
dc.identifier.citation<p>Mishra A, George AA, Sahu KK, Lal A, Abraham G. Tuberculosis and COVID-19 Co-infection: An Updated Review. Acta Biomed. 2020 Nov 10;92(1):e2021025. doi: 10.23750/abm.v92i1.10738. PMID: 33682808. <a href="https://doi.org/10.23750/abm.v92i1.10738">Link to article on publisher's site</a></p>
dc.identifier.issn0392-4203 (Linking)
dc.identifier.doi10.23750/abm.v92i1.10738
dc.identifier.pmid33682808
dc.identifier.urihttp://hdl.handle.net/20.500.14038/27388
dc.description<p>Article title taken from published PDF. Article title in PubMed: Tuberculosis and COVID-19 Co-infection: An Updated Review.</p>
dc.description.abstractCoronavirus disease (COVID 19) has involved millions of people all over the world. Tuberculosis (TB) continues to affect millions of people every year with high mortality. There is limited literature on the occurrence of COVID 19 in patients with TB. We reviewed the available data on various clinical details, management, and outcome among patients with COVID-19 and TB. 8 studies reported a total of 80 patients with this coinfection. These patients were reported from ten different countries, with Italy reporting the largest number of cases. Migrant, males constituted a major proportion of cases. Most reported patients were symptomatic. Fever, dry cough, and dyspnea were the most commonly reported symptoms. Bilateral ground glass opacities were more common in COVID 19 infection and cavitary lesions were more common in patients with TB. Most reported TB patients had been found to have mycobacterium tuberculosis from sputum culture in the background of pulmonary TB. Most patients of TB were treated with multidrug regimen antitubercular therapy. In all 8 studies, COVID 19 was treated as per the local protocol. Mortality was reported in more than 10% of patients. Mortality was higher in elderly patients ( > 70 years) and amongst patient with multiple medical comorbidities.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=33682808&dopt=Abstract">Link to Article in PubMed</a></p>
dc.relation.urlhttps://www.mattioli1885journals.com/index.php/actabiomedica/article/view/10738
dc.rightsCopyright : © 2020 ACTA BIO MEDICA SOCIETY OF MEDICINE AND NATURAL SCIENCES OF PARMA. This work is licensed under a Creative Commons Attribution 4.0 International License
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectTuberculosis
dc.subjectCOVID-19
dc.subjectDiagnosis
dc.subjectOutcome
dc.subjectMortality
dc.subjectEvidence
dc.subjectBacterial Infections and Mycoses
dc.subjectInfectious Disease
dc.subjectVirus Diseases
dc.titleReview of clinical profile, risk factors, and outcome in patients with Tuberculosis and COVID -19
dc.typeJournal Article
dc.source.journaltitleActa bio-medica : Atenei Parmensis
dc.source.volume92
dc.source.issue1
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=1187&amp;context=covid19&amp;unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/covid19/184
dc.identifier.contextkey22135730
refterms.dateFOA2022-08-23T15:44:46Z
html.description.abstract<p>Coronavirus disease (COVID 19) has involved millions of people all over the world. Tuberculosis (TB) continues to affect millions of people every year with high mortality. There is limited literature on the occurrence of COVID 19 in patients with TB. We reviewed the available data on various clinical details, management, and outcome among patients with COVID-19 and TB. 8 studies reported a total of 80 patients with this coinfection. These patients were reported from ten different countries, with Italy reporting the largest number of cases. Migrant, males constituted a major proportion of cases. Most reported patients were symptomatic. Fever, dry cough, and dyspnea were the most commonly reported symptoms. Bilateral ground glass opacities were more common in COVID 19 infection and cavitary lesions were more common in patients with TB. Most reported TB patients had been found to have mycobacterium tuberculosis from sputum culture in the background of pulmonary TB. Most patients of TB were treated with multidrug regimen antitubercular therapy. In all 8 studies, COVID 19 was treated as per the local protocol. Mortality was reported in more than 10% of patients. Mortality was higher in elderly patients ( > 70 years) and amongst patient with multiple medical comorbidities.</p>
dc.identifier.submissionpathcovid19/184
dc.contributor.departmentDepartment of Medicine
dc.source.pagese2021025


Files in this item

Thumbnail
Name:
ACTA_92_25.pdf
Size:
127.2Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Copyright : © 2020 ACTA BIO MEDICA SOCIETY OF MEDICINE AND NATURAL SCIENCES OF PARMA. This work is licensed under a Creative Commons Attribution 4.0 International License
Except where otherwise noted, this item's license is described as Copyright : © 2020 ACTA BIO MEDICA SOCIETY OF MEDICINE AND NATURAL SCIENCES OF PARMA. This work is licensed under a Creative Commons Attribution 4.0 International License